Association of UGT1A1*6 , UGT1A1*28 , or ABCC2 c.3972C>T genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Association of
UGT1A1*6
,
UGT1A1*28
, or
ABCC2 c.3972C>T
genetic polymorphisms with irinotecan‐induced toxicity in Asian cancer patients: Meta‐analysis
Authors
Keywords
-
Journal
CTS-Clinical and Translational Science
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-05-04
DOI
10.1111/cts.13277
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- UGT1A1 Gene Polymorphisms in Patients with Small Cell Lung Cancer Treated with Irinotecan‐Platinum Doublet Chemotherapy and Their Association with Gastrointestinal Toxicity and Overall Survival
- (2021) Ankan Bandyopadhyay et al. ONCOLOGIST
- The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
- (2021) Matthew J Page et al. BMJ-British Medical Journal
- Correlation between UGT1A1 gene polymorphism and irinotecan chemotherapy in metastatic colorectal cancer: a study from Guangxi Zhuang
- (2020) Shaojun Chen et al. BMC GASTROENTEROLOGY
- UGT1A1 polymorphism has a prognostic effect in patients with stage IB or II uterine cervical cancer and one or no metastatic pelvic nodes receiving irinotecan chemotherapy: a retrospective study
- (2020) Hideki Matsuoka et al. BMC CANCER
- Pharmacogenetic impact of UGT1A1 polymorphisms on pulmonary neuroendocrine tumours treated with metronomic irinotecan‐based chemotherapy in Chinese populations
- (2020) Xu Ma et al. JOURNAL OF PHARMACY AND PHARMACOLOGY
- Risk of major adverse cardiovascular events of CYP2C19 loss-of-function genotype guided prasugrel/ticagrelor vs clopidogrel therapy for acute coronary syndrome patients undergoing percutaneous coronary intervention: a meta-analysis
- (2020) Mohitosh Biswas et al. PLATELETS
- Effect of drug metabolizing enzymes and transporters in Thai colorectal cancer patients treated with irinotecan-based chemotherapy
- (2020) Chalirmporn Atasilp et al. Scientific Reports
- Association of UGT1A1*6 polymorphism with irinotecan-based chemotherapy reaction in colorectal cancer patients: a systematic review and a meta-analysis
- (2020) Xiaoyun Zhu et al. BIOSCIENCE REPORTS
- Association between UGT1A1 gene polymorphism and safety and efficacy of irinotecan monotherapy as the third-line treatment for advanced gastric cancer
- (2019) Toshifumi Yamaguchi et al. Gastric Cancer
- UGT1A1*6 and UGT1A1*28 polymorphisms are correlated with irinotecan-induced toxicity: A meta-analysis
- (2018) Yuwei Yang et al. Asia-Pacific Journal of Clinical Oncology
- UGT1A1 polymorphisms in rectal cancer associated with the efficacy and toxicity of preoperative chemoradiotherapy using irinotecan
- (2018) Kei Kimura et al. CANCER SCIENCE
- A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101)
- (2017) Koji Ando et al. International Journal of Clinical Oncology
- Relationship between UGT1A1*6/*28 gene polymorphisms and the efficacy and toxicity of irinotecan-based chemotherapy
- (2017) Yu Bai et al. OncoTargets and Therapy
- UGT1A1 gene polymorphism is associated with toxicity and clinical efficacy of irinotecan-based chemotherapy in patients with advanced colorectal cancer
- (2016) Chunlei Xu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Correlation of UGT1A1 * 28 and * 6 polymorphisms with irinotecan-induced neutropenia in Thai colorectal cancer patients
- (2016) Chalirmporn Atasilp et al. Drug Metabolism and Pharmacokinetics
- Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patients
- (2015) Naoki Horikawa et al. BMC CANCER
- UGT1A1genotype and irinotecan therapy: general review and implementation in routine practice
- (2015) Marie-Christine Etienne-Grimaldi et al. FUNDAMENTAL & CLINICAL PHARMACOLOGY
- Correlation of UGT1A1 and ERCC1 gene polymorphisms with the outcome of combined irinotecan plus cisplatin treatment in recurrent ovarian cancer
- (2015) Q. Xu et al. GENETICS AND MOLECULAR RESEARCH
- The relationship between UGT1A1 gene polymorphism and irinotecan effect on extensive-stage small-cell lung cancer
- (2015) Xiaoguang Xiao et al. OncoTargets and Therapy
- Cisplatin combined with irinotecan or etoposide for untreated extensive-stage small cell lung cancer: A multicenter randomized controlled clinical trial
- (2015) Yuankai Shi et al. Thoracic Cancer
- Clinical Observations on Associations Between the UGT1A1 Genotype and Severe Toxicity of Irinotecan
- (2014) Yan-Yan Lu et al. Asian Pacific Journal of Cancer Prevention
- Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
- (2014) Fei-fei Han et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- UGT1A1*6 polymorphisms are correlated with irinotecan-induced toxicity: a system review and meta-analysis in Asians
- (2014) Lei Cheng et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Pharmacogenomics of Human Uridine Diphospho-Glucuronosyltransferases and Clinical Implications
- (2014) C Guillemette et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Uridine diphosphate glucuronide transferase 1A1FNx0128 gene polymorphism and the toxicity of irinotecan in recurrent and refractory small cell lung cancer
- (2014) Xie Conghua et al. Journal of Cancer Research and Therapeutics
- Initial Therapy with FOLFOXIRI and Bevacizumab for Metastatic Colorectal Cancer
- (2014) Fotios Loupakis et al. NEW ENGLAND JOURNAL OF MEDICINE
- Association between the low-dose irinotecan regimen-induced occurrence of grade 4 neutropenia and genetic variants of UGT1A1 in patients with gynecological cancers
- (2014) HIROYUKI MORIYA et al. Oncology Letters
- UGT1A1 Gene Polymorphisms and the Toxicities of FOLFIRI in Chinese Han Patients with Gastrointestinal Cancer
- (2013) Chen-fei Zhou et al. Anti-Cancer Agents in Medicinal Chemistry
- The association of UGT1A1*6 and UGT1A1*28 with irinotecan-induced neutropenia in Asians: a meta-analysis
- (2013) Yi-Jing Chen et al. BIOMARKERS
- Polymorphisms in the UGT1A1 gene predict adverse effects of irinotecan in the treatment of gynecologic cancer in Japanese patients
- (2013) Akira Hirasawa et al. JOURNAL OF HUMAN GENETICS
- Associations between UGT1A1*6/*28 polymorphisms and irinotecan-induced severe toxicity in Chinese gastric or esophageal cancer patients
- (2013) Jing Gao et al. MEDICAL ONCOLOGY
- UGT1A1*6/*28 polymorphisms could predict irinotecan-induced severe neutropenia not diarrhea in Chinese colorectal cancer patients
- (2013) Jing Gao et al. MEDICAL ONCOLOGY
- Association of UGT1A1*28 polymorphisms with irinotecan-induced toxicities in colorectal cancer: a meta-analysis in Caucasians
- (2013) X Liu et al. PHARMACOGENOMICS JOURNAL
- Phase II and UGT1A1 genotype study of irinotecan dose escalation as salvage therapy for advanced gastric cancer
- (2012) J-C Jo et al. BRITISH JOURNAL OF CANCER
- Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer
- (2012) Naminatsu Takahara et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- A Phase II Study of Clinical Outcomes of 3-Week Cycles of Irinotecan and S-1 in Patients with Previously Untreated Metastatic Colorectal Cancer: Influence of theUGT1A1andCYP2A6Polymorphisms on Clinical Activity
- (2012) Yoon Hee Choi et al. ONCOLOGY
- UGT1A1predicts outcome in colorectal cancer treated with irinotecan and fluorouracil
- (2012) Yan Wang WORLD JOURNAL OF GASTROENTEROLOGY
- Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1*28 and/or UGT1A1*6 polymorphisms
- (2011) Taroh Satoh et al. CANCER SCIENCE
- Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms
- (2011) Y. Okuyama et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Phase II study of a triplet regimen of S-1 combined with irinotecan and oxaliplatin in patients with metastatic gastric cancer: clinical and pharmacogenetic results
- (2010) S. R. Park et al. ANNALS OF ONCOLOGY
- UGT1A1*1/*28 and *1/*6 genotypes have no effects on the efficacy and toxicity of FOLFIRI in Japanese patients with advanced colorectal cancer
- (2010) Yu Sunakawa et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Dose-Dependent Association between UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Low Doses Also Increase Risk
- (2010) Z.-Y. Hu et al. CLINICAL CANCER RESEARCH
- Randomized Phase II Trial of Irinotecan with Paclitaxel or Gemcitabine for Non-small Cell Lung Cancer: Association of UGT1A1*6 and UGT1A1*27 with Severe Neutropenia
- (2010) Yoichi Nakamura et al. Journal of Thoracic Oncology
- UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients
- (2009) Masahide Onoue et al. International Journal of Clinical Oncology
- Clinical Significance of UDP-Glucuronosyltransferase 1A1*6 for Toxicities of Combination Chemotherapy with Irinotecan and Cisplatin in Gynecologic Cancers
- (2009) Masashi Takano et al. ONCOLOGY
- UGT1A1*28 polymorphism predicts irinotecan-induced severe toxicities without affecting treatment outcome and survival in patients with metastatic colorectal carcinoma
- (2008) Chun-Yu Liu et al. CANCER
- Phase I/II Pharmacokinetic and Pharmacogenomic Study of UGT1A1 Polymorphism in Elderly Patients With Advanced Non–Small Cell Lung Cancer Treated With Irinotecan
- (2008) N Yamamoto et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Integrated pharmacogenetic prediction of irinotecan pharmacokinetics and toxicity in patients with advanced non-small cell lung cancer
- (2008) Ji-Youn Han et al. LUNG CANCER
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started